About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in California | 1,207 Studies

Clinical Trials Prostate CancerCalifornia

Prostate Cancer Clinical Trials in California

Find 1,207 clinical trials for prostate cancer near California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 581-600 of 1,207 trials

TerminatedA Study of Oral CFG920 in Patients With Castration Resistant Prostate CancerThis study was supposed to have assessed the safety and preliminary antitumor activity of CFG920, a new CYP17 inhibitor in castration resistant prostate cancer patients who are…NCT01647789·San Francisco, California and 6 others TerminatedPhase II, Dose Finding Study of GTx-758The purpose of this study is to determine the appropriate loading and maintenance dose of GTx-758 to reach and maintain castration for the duration of the study.NCT01393119·Glendale, Arizona and 20 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSafety and Tolerability Study Using WST11 In Patients With Localized Prostate CancerThe aim of this study is to determine the optimal treatment conditions (WST11 dose and light energy dose) to achieve ablation in one lobe of the prostate and to evaluate the…NCT00946881·Los Angeles, California and 4 others

CompletedHypofractionated Stereotactic Body Radiation Therapy (SBRT)The purpose of this study is to evaluate the safety and tolerability of using radiation therapy with 5 fractions of radiation to treat prostate cancer with guidance of radiation…NCT01288534·Sacramento, California and 1 other

CompletedA Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.The purpose of the study is to assess if the addition of darolutamide to ADT compared with ADT alone would result in superior clinical efficacy in participants with metastatic…NCT05059236·Homewood, Alabama and 30 others

CompletedThe Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting OsteoporosisThis study is being conducted to evaluate the effect of an investigational drug on bone loss in men with prostate cancer who are receiving Androgen Deprivation Therapy (ADT).NCT00171639·Tucson, Arizona and 6 others

RecruitingREGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell CarcinomaThis study is researching a new drug called REGN15505 when used alone or in combination with cemiplimab or in combination with REGN4336 in adult patients with mCRPC and ccRCC.NCT07594106·Goodyear, Arizona and 5 others

CompletedADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)A Phase 1/2 multicenter, dose determining, open-label study of ADXS31-142 monotherapy and a combination of ADXS31-142 and pembrolizumab (MK-3475) in participants with metastatic…NCT02325557·San Francisco, California and 7 others

CompletedARI103094-Follow-Up Study for REDUCE Study SubjectsARI103094 is a follow-up study in adult male subjects who have received investigational product (either dutasteride or placebo) in the REDUCE Study (REduction by DUasteride of…NCT00883909·Anchorage, Alaska and 266 others

CompletedAn Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant…NCT03338790·Daphne, Alabama and 65 others

TerminatedTreatment Resistance Following Anti-cancer TherapiesThe TRANSLATE study aims to better understand why tumors become resistant to standard anti-cancer therapies.NCT04436120·Daphne, Alabama and 32 others

CompletedWhite Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local TherapyRATIONALE: White button mushroom extract may stop or delay the development of recurrent prostate cancer.NCT00779168·Duarte, California and 1 other

CompletedTrial of NanoPac® Focal Therapy in Subjects With Prostate CancerOpen-label, dose rising, Phase IIa trial of intratumorally-injected NanoPac® 6, 10, or 15 mg/mL in subjects with prostate cancer scheduled for prostatectomy.NCT03077659·Los Angeles, California

Active not recruitingTesting the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE StudyThis phase III trial compares the effect of adding darolutamide to ADT versus ADT alone after surgery for the treatment of high-risk prostate cancer.NCT04484818·Duarte, California and 114 others

CompletedRCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)This is a two-arm, randomized, controlled trial to evaluate the effectiveness of using a behaviorally designed gamification intervention with social support compared to an…NCT05176756·Duarte, California and 1 other

CompletedSafety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway InhibitorThis study is designed to assess the safety and tolerability of atezolizumab when given in combination with radium-223 dichloride in participants with metastatic CRPC who have…NCT02814669·Duarte, California and 16 others

CompletedUse of Hypothermia During Robotic ProstatectomyRobotic assisted laparoscopic radical prostatectomy (RLP) has gained widespread acceptance as a standard treatment for clinically localized prostate cancer.NCT00915031·Orange, California

RecruitingStudy With [225Ac]Ac-FL-020 in mCRPC ParticipantsThe purpose of this study is to evaluate the safety, therapeutic effect, and pharmacokinetics of \[225Ac\]Ac-FL-020 in participants with metastatic castration-resistant prostate…NCT06492122·Duarte, California and 10 others

TerminatedInvestigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound ImagingTrans-perineal focal laser ablation represents a promising alternative focal therapy option for patients with low-risk or favorable intermediate risk prostate cancer.NCT05826470·San Diego, California

TerminatedTaxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer PatientsRATIONALE: Drugs used in chemotherapy, such as docetaxel and prednisone, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00879619·Orange, California

PreviousPage 30 of 61Next

Other Conditions in California

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma